Biodegradable pancreatic stents: are they a disappearing wonder?

Gastrointestinal Endoscopy

Volumn 67, Issue 7, 2008, Pages 1113-1116

  Bhasin, Deepak K ^a   Rana, Surinder S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLYCOLIDE; POLYLACTIDE;

BIODEGRADABLE IMPLANT; CHOLANGIOGRAPHY; EDITORIAL; HUMAN; NONHUMAN; PANCREAS DUCT; PANCREAS DUCT STENOSIS; PANCREAS FISTULA; PANCREAS PSEUDOCYST; PANCREATIC STENT; PANCREATITIS; PRIORITY JOURNAL; SPHINCTEROTOMY; STENT;

ABSORBABLE IMPLANTS; ANIMALS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DISEASE MODELS, ANIMAL; HUMANS; PANCREATIC DISEASES; PANCREATIC DUCTS; PROSTHESIS DESIGN; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STENTS; SWINE;

EID: 44149089058     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2007.12.036     Document Type: Editorial

References (38)

1. Delhaye M., Arvanitakis M., Verset G., et al. Long-term clinical outcome after endoscopic pancreatic ductal drainage for patients with painful chronic pancreatitis. Clin Gastroenterol Hepatol 2 (2004) 1096-1106
2. Bhasin D.K., Rana S.S., Udawat H.P., et al. Management of multiple and large pseudocysts by endoscopic transpapillary drainage alone. Am J Gastroenterol 101 (2006) 1780-1786
3. Kozarek R.A., Ball T.J., Patterson D.J., et al. Endoscopic transpapillary therapy for disrupted pancreatic duct and peripancreatic fluid collections. Gastroenterology 100 (1991) 1362-1370
4. Carr-Locke D.L. Endoscopic therapy of chronic pancreatitis. Gastrointest Endosc 49 Suppl (1999) S77-S80
5. Varadarajulu S., Noone T.C., Tutuian R., et al. Predictors of outcome in pancreatic duct disruption managed by endoscopic transpapillary stent placement. Gastrointest Endosc 61 (2005) 568-575
6. Freeman M.L. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 5 (2007) 1354-1365
7. Costamagna G., Bulajic M., Tringali A., et al. Multiple stenting of refractory pancreatic duct strictures in severe chronic pancreatitis: long-term results. Endoscopy 38 (2006) 254-259
8. Lehman G.A. Role of ERCP and other endoscopic modalities in chronic pancreatitis. Gastrointest Endosc 56 6 Suppl (2002) S237-S240
9. Farnbacher M.J., Voll R.E., Faissner R., et al. Composition of clogging material in pancreatic endoprostheses. Gastrointest Endosc 61 (2005) 862-866
10. Ikenberry S.O., Sherman S., Hawes R.H., et al. The occlusion rate of pancreatic stents. Gastrointest Endosc 40 (1994) 611-613
11. Deviere J. Why do pancreatic stents become occluded?. Gastrointest Endosc 61 (2005) 867-868
12. Davis P.H., Groen A.K., Rauws E.A., et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstructions. Lancet 340 (1992) 1488-1492
13. Tham T.C., Lichtenstein D.R., Vandervoort J., et al. Pancreatic duct stents for "obstructive type" pain in pancreatic malignancy. Am J Gastroenterol 95 (2000) 956-960
14. Keeley S.P., and Freeman M.L. Placement of self-expanding metallic stents in the pancreatic duct for treatment of obstructive complications of pancreatic cancer. Gastrointest Endosc 57 (2003) 756-759
15. Bethge N., Sommer A., Gross U., et al. Human tissue responses to metal stents implanted in vivo for the palliation of malignant stenosis. Gastrointest Endosc 43 (1996) 596-602
16. Venkatraman S., Poh T.L., Vinalia T., et al. Collapse pressures of biodegradable stents. Biomaterials 24 (2003) 2105-2111
17. Freeman M.L. Bioabsorbable stents for gastrointestinal endoscopy. Tech Gastrointest Endosc 3 (2001) 120-125
18. Parviainen M., Sand J., Harmoinen A., et al. A new biodegradable stent for the pancreaticojejunal anastomosis after pancreaticoduodenal resection: in vitro examination and pilot experiences in humans. Pancreas 21 (2000) 14-21
19. Lumiaho J., Heino A., Tunninen V., et al. New bioabsorbable polylactide ureteral stent in the treatment of ureteral lesions: an experimental study. J Endourol 13 (1999) 107-112
20. Isotalo T., Talja M., Hellstrom P., et al. A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly l-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from benign prostatic hyperplasia. BJU Int 88 (2001) 30-34
21. Isotalo T., Nuutinen J.P., Vaajanen A., et al. Biocompatibility and implantation properties of 2 differently braided, biodegradable, self-reinforced polylactic acid urethral stents: an experimental study in the rabbit. J Urol 174 (2005) 2401-2404
22. Tamai H., Igaki K., Kyo E., et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 102 (2000) 399-404
23. Bunger C.M., Grabow N., Strenberg K., et al. Sirolimus-eluting biodegradable poly-l-lactide stent for peripheral vascular application: a preliminary study in porcine carotid arteries. J Surg Res 139 (2007) 77-82
24. Goldin E., Fiorini A., Ratan Y., et al. A new biodegradable and self-expanding stent for benign esophageal strictures. [abstract]. Gastrointest Endosc 43 (1996) 294
25. Fry S.W., and Fleischer D.E. Management of a refractory benign esophageal stricture with a new biodegradable stent. Gastrointest Endosc 45 (1997) 179-182
26. Tanaka T., Takahashi M., Nitta N., et al. Newly developed biodegradable stents for benign gastrointestinal tract stenoses: a preliminary clinical trial. Digestion 74 (2006) 199-205
27. Saito Y., Tanaka T., Andoh A., et al. Usefulness of biodegradable stents constructed of poly-l-lactic acid monofilaments in patients with benign esophageal stenosis. World J Gastroenterol 13 (2007) 3977-3980
28. Haber G.B., Freeman M.L., Bedford R., et al. A prospective multi-center study of a bioabsorbable biliary Wallstent in 50 patients with malignant obstructive jaundice. [abstract]. Gastrointest Endosc 53 (2001) AB121
29. Ginsberg G., Cope C., Shah J., et al. In vivo evaluation of a new bioabsorbable self-expanding biliary stent. Gastrointest Endosc 58 (2003) 777-784
30. Meng B., Wang J., Zhu N., et al. Study of biodegradable and self-expandable PLLA helical biliary stent in vivo and in vitro. J Mater Sci Mater Med 17 (2006) 611-617
31. Laukkarinen J., Nordback I., Mikkonen J., et al. A novel biodegradable biliary stent in the endoscopic treatment of cystic-duct leakage after cholecystectomy. Gastrointest Endosc 65 (2007) 1063-1068
32. Laukkarinen J.M., Sand J.A., Chow P., et al. A novel biodegradable biliary stent in the normal duct hepaticojejunal anastomosis: an 18-month follow-up in a large animal model. J Gastrointest Surg 11 (2007) 750-757
33. Laukkarinen J., Lämsä T., Nordback I., et al. A novel biodegradable pancreatic stent for human pancreatic applications: a preclinical safety study in a large animal model. Gastrointest Endosc 67 (2008) 1106-1112
34. Lämsä T., Haitao J., Mikkonen J., et al. Biocompatibility of a new bioabsorbable radiopaque stent material (BaSO4 containing poly-d, l-lactide) in the rat pancreas. Pancreatology 6 (2006) 301-305
35. Sherman S., Hawes R.H., Savides T.J., et al. Stent-induced pancreatic ductal and parenchymal changes: correlation of endoscopic ultrasound with ERCP. Gastrointest Endosc 44 (1996) 276-282
36. Smith M.T., Sherman S., Ikenberry S.O., et al. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc 44 (1996) 268-275
37. Heublein B., Rohde R., Kaese V., et al. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?. Heart 89 (2003) 651-656
38. Erbel R., Di Mario C., Bartunek J., et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 369 (2007) 1869-1875